December 29, 2021
In this podcast directed to physicians, Dr. Lewis Blevins shares his vast experience of 30 years treating patients with central hypothyroidism.
December 9, 2021
In the last podcast in the series on the drugs available to manage hypercortisolism, Dr. Blevins discusses mifepristone, trade name Korlym®.
December 8, 2021
This is the fourth podcast in a series of five on medications to treat Cushing’s disease. Today Dr. Blevins discusses Pasireotide, trade names Signifor and Signifor LAR.
December 6, 2021
Our third podcast in the series is on osilodrostat (trade name Isturisa®), a drug approved by the FDA in the US and the European Medicines Agency (EMA) to treat hypercortisolism in patients who are not candidates for surgery or those that surgery did not work. In this podcast, Dr. BLevins takes us inside his clinical practice to share his experiences with the drug.
December 3, 2021
The second podcast in our series on the medical management of hypercortisolism focuses on the drug metyrapone. Dr. Blevins discusses the drug uses, how it works, and its side effects.
Coming up next, a discussion on the drug Isturiza® (osilodrostat).
December 2, 2021
This is the first in our series of five podcasts on the medical management of Hypersortisolism due to Cushing's disease. Today Dr. Blevins discusses the drug Ketoconazole.